Breaking news

The mental health impact of the COVID-19 pandemic on people with and without depressive, anxiety, or obsessive-compulsive disorders: a longitudinal study of three Dutch case-control cohorts

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study

Renin–angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis

Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

Baricitinib plus Remdesivir for Hospitalized Adults with COVID-19

Efficacy of Tocilizumab in Patients Hospitalized with COVID-19

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with COVID-19

A Neutralizing Monoclonal Antibody for Hospitalized Patients with COVID-19

Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine

Mononeuritis multiplex: an unexpectedly frequent feature of severe COVID-19

Impact of COVID-19 pandemic lockdown on narcolepsy type 1 management

Cerebrospinal fluid features in COVID-19 patients with neurologic manifestations: correlation with brain MRI findings in 58 patients

Neurological Predictors of Clinical Outcomes in Hospitalized Patients With COVID-19

COVID-19 in patients with multiple sclerosis undergoing disease-modifying treatments